Peter Wijngaard
CIK 1778501 · Chief Development Officer · last filed 2023-11-28
Peter Wijngaard is a Chief Development Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider bought $15.3K of HEPA on Nov 28, 2023. Across all open-market trades the lifetime net is +$92.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $760 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$760
2
10
$92.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HEPA | Director | 9,501 | $0.08 | $760 | $92.4K | 7 | 2023-11-28 |
| MEDICINES CO /DE (MDCO) Delisted | Chief Development Officer | 0 | — | — | $0 | 3 | 2020-01-06 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-28 | HEPA | Buy (P) | +5,000 | $15.3K | EDGAR |
| 2023-09-20 | HEPA | Buy (P) | +3,000 | $16.8K | EDGAR |
| 2021-05-20 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | HEPA | Buy (P) | +10,000 | $22.0K | EDGAR |
| 2020-12-21 | HEPA | Buy (P) | +20,000 | $38.2K | EDGAR |
| 2020-08-21 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | HEPA | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | MEDICINES CO /DE (MDCO) Delisted | Disp (D) | −107,546 | $0 | EDGAR |
| 2019-12-31 | MEDICINES CO /DE (MDCO) Delisted | Mixed | +105,098 | -$8.65M | EDGAR |
| 2019-09-04 | MEDICINES CO /DE (MDCO) Delisted | Grant (A) | +491 | $10.6K | EDGAR |